Clinical Protocols

Depression

Treatment-Resistant Depression: The Cause-First Workup Before TMS. Part of the Clinical Protocols library by Dr. med. univ. Julian Douwes

12 articles · 119 min total
01
Foundational

What Is TMS? Transcranial Magnetic Stimulation Explained

Transcranial magnetic stimulation explained by a physician. TMS vs TPS, FDA clearance, session protocols, and why I rank TPS as the top neuromodulation tool in my practice.

What Is TMS? Transcranial Magnetic Stimulation Explained
02

At-Home Brain Stimulation for Depression: ProlivRx and Flow FL-100 — What the 2025–2026 FDA Approvals Mean for Patients

Two FDA-approved at-home brain stimulation devices for depression are now available. Here is what the clinical evidence says and when they are — or are not — the right choice.

At-Home Brain Stimulation for Depression: ProlivRx and Flow FL-100 — What the 2025–2026 FDA Approvals Mean for Patients
03

CRP and Depression: What Inflammation Testing Reveals Before You Start TMS

CRP and cytokine testing before TMS for depression identifies the inflamed subtype, predicts response, and guides whether inflammation must be treated first.

CRP and Depression: What Inflammation Testing Reveals Before You Start TMS
04

Ketamine as a Bridge to TMS: The Induction Protocol for Treatment-Resistant Depression

When TMS for depression takes weeks to build effect, IV ketamine can bridge the gap — acute relief while circuits remodel. Protocol, evidence, and patient selection.

Ketamine as a Bridge to TMS: The Induction Protocol for Treatment-Resistant Depression
05

Accelerated TMS in 2026: SWIFT, 5×5 rTMS, and Faster Routes to Depression Remission

SWIFT deep TMS and 5×5 accelerated rTMS compress depression treatment to 5–6 days. What the 2026 evidence shows, who qualifies, and how Julian positions these protocols.

Accelerated TMS in 2026: SWIFT, 5×5 rTMS, and Faster Routes to Depression Remission
06

Treatment-Resistant Depression: The Cause-First Workup Before TMS

Before treating TRD, investigate the cause: qEEG brain mapping, CRP inflammation testing, Lyme/viral infections, and toxic relationships. Julian's clinical protocol.

Treatment-Resistant Depression: The Cause-First Workup Before TMS
07

ECT Must Be Banned: A Treatment With No Going Back

A physician's case for banning electroconvulsive therapy: permanent memory loss, falling brain metabolism on PET and SPECT, high relapse, thin consent, and the targeted alternatives.

ECT Must Be Banned: A Treatment With No Going Back
08

PE-22-28 (Mini-Spadin): A TREK-1 Peptide Tested Only in Mice

PE-22-28 is a 7-amino-acid spadin analog that blocks the TREK-1 channel and acted as a fast antidepressant in mice. No human has received it in a study.

PE-22-28 (Mini-Spadin): A TREK-1 Peptide Tested Only in Mice
09

Ketamine Infusion Therapy: Protocol, Evidence, and Who Benefits

A clinical guide to IV ketamine infusions for treatment-resistant depression and chronic pain — dosing, mechanism, patient selection, and realistic expectations.

Ketamine Infusion Therapy: Protocol, Evidence, and Who Benefits
10

Vitamin D as a Neuroimmune Signal: Mental Health Applications Beyond Bone

How vitamin D acts as a lifespan neuroimmune signal in psychiatry — from depression and schizophrenia to autism and cognitive decline. Clinical dosing and evidence.

Vitamin D as a Neuroimmune Signal: Mental Health Applications Beyond Bone
11

Photobiomodulation for Depression: What the Clinical Evidence Actually Shows

Dr. Douwes reviews transcranial photobiomodulation for depression — mechanisms, clinical trial data, dosing protocols, and how it fits an integrative mental health strategy.

Photobiomodulation for Depression: What the Clinical Evidence Actually Shows
12

TMS for Depression: What 20 Years of Evidence Shows

TMS depression treatment explained by a physician. FDA clearance history, rTMS protocols, theta burst stimulation, response rates, and who responds best.

TMS for Depression: What 20 Years of Evidence Shows
← Back to Clinical Protocols